ITeos Therapeutics Inc (NASDAQ:ITOS) currently has a daily average trading volume of 1.10M but it saw 3770303 shares traded in last market. With a market cap of 383.88M USD, the company’s current market price of $10.03 came falling about -0.30 while comparing to the previous closing price of $10.06. In past 52 weeks, the stock remained buoying in the range of price level as high as $18.13 and as low as $4.80.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Wells Fargo which downgraded the stock as “Equal Weight” in its note to investors issued on May 28, 2025, recommending a price target of $12 for it. Wedbush downgraded its recommendation for the stock as a “Neutral” from “Outperform” on May 28, 2025 while assigning a price target of $12. Leerink Partners also issued its recommendations for the stock as it downgraded the price target for the stock is $9.
Over the week, ITOS’s stock price is moving 22.02% up while it is 46.42% when we observe its performance for the past one month. Year-to-date it is 30.60% up and over the past year, the stock is showing a downside performance of -43.27%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.8 while estimate for next year EPS is -2.97.
Currently, ITeos Therapeutics Inc’s total number of outstanding shares is 38.27M with 1.14% of that held by the insiders while 111.04% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -23.07% and return on equity (ROE) at -23.68%. Stock’s beta reads 1.51. Stock has a price to book (P/B) ratio of 0.68 while price to sale or P/S ratio amounts to 10.97. Its return on asset (ROA) is -20.30% on average.
